PRESS

Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular diseases, is attending the annual J.P. Morgan Healthcare Conference in San Francisco.

San Francisco, September 15, 2025 - Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular diseases , announced today that it is participating in the LSX World Congress USA in Boston. Recardio at LSX World Congress USA The congress gathers leaders from the US Biotech, Medtech, and Pharmatech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pha

Newly Granted Patent Application improves Patient Compliance